Shandong Lukang Pharmaceutical Co.,Ltd. (SHA:600789)

China · Delayed Price · Currency is CNY

7.38

+0.07 (0.96%)

Jul 29, 2026, 3:00 PM CST

-32.36% (1Y)

Market Cap	7.71B -21.3%
Revenue (ttm)	5.71B -6.5%
Net Income	86.96M -78.6%
EPS	0.09 -80.3%
Shares Out	1.05B
PE Ratio	83.49
Forward PE	n/a
Dividend	0.05 (0.68%)
Ex-Dividend Date	Jul 15, 2026

Volume	18,595,932
Open	7.35
Previous Close	7.31
Day's Range	7.31 - 7.42
52-Week Range	6.48 - 11.30
Beta	0.22
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 29, 2026

About SHA:600789

Shandong Lukang Pharmaceutical Co.,Ltd. operates as a pharmaceutical company in China. The company offers systemic anti-infectives, hypoglycemic agents, cardiovascular and cerebrovascular drugs, respiratory medicines, neurodegenerative disease treatments, digestive and metabolic disease drugs, antitumor drugs, and traditional Chinese and Tibetan medicines. The company also provides synthetic biology products, including trans-aconitic acid, perillyl alcohol, bisabolol, and patchouli alcohol, and engages in the production and sale of feed additiv... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1966

Employees 6,469

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 600789

Full Company Profile

Financial Performance

In 2025, SHA:600789's revenue was 5.77 billion, a decrease of -7.49% compared to the previous year's 6.23 billion. Earnings were 112.30 million, a decrease of -71.54%.

Financial Statements